Effects of phencyclidine (PCP)-like drugs on turning behavior, 3H-dopamine uptake, and 3H-PCP binding

Kenneth M. Johnson, Lawrence D. Snell

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

In this study representatives from three chemical classes which are known to produce a phencyclidine (PCP)-like discriminative stimulus cue in rats were tested for their ability to inhibit synaptosomal uptake of 3H-dopamine (3H-DA) and to compete for a binding site labeled with 3H-PCP. Although there was a good correlation between these two in vitro activities within the arylcycloalkylamine class (PCP, N-ethyl-phenylcyclohexylamine (PCE), and ketamine) it did not hold when representatives from the benzomorphans, N-allylnormetazocine (NANM), cyclazocine (CYCL), and ethylketocyclazocine (EKC), or a substituted dioxolane (etoxadrol) were included. At some dose each of these drugs with the exception of EKC also produced ipsilateral turning in rats with a unilateral 6-hydroxydopamine lesion of the substantia nigra. This effect was also not well correlated with inhibition of 3H-DA uptake. However, a significant correlation was found to exist between turning behavior and affinity for the putative PCP/sigma receptor. The possibility that a non-dopaminergic mechanism involving the PCP/sigma receptor underlies the ability of these agents to induce turning behavior is discussed.

Original languageEnglish
Pages (from-to)731-735
Number of pages5
JournalPharmacology, Biochemistry and Behavior
Volume22
Issue number5
DOIs
StatePublished - 1985

Fingerprint

Phencyclidine
Phencyclidine Receptors
Ethylketocyclazocine
sigma Receptors
Dopamine
Aptitude
Benzomorphans
Cyclazocine
Pharmaceutical Preparations
Oxidopamine
Ketamine
Substantia Nigra
Rats
Cues
Binding Sites

Keywords

  • H-Phencyclidine binding
  • Cyclazocine
  • Dopamine uptake
  • Ethylketocyclazocine
  • Etoxadrol
  • Ketamine
  • N-Allylnormetazocine
  • Phencyclidine
  • Turning behavior

ASJC Scopus subject areas

  • Biochemistry
  • Behavioral Neuroscience
  • Pharmacology

Cite this

Effects of phencyclidine (PCP)-like drugs on turning behavior, 3H-dopamine uptake, and 3H-PCP binding. / Johnson, Kenneth M.; Snell, Lawrence D.

In: Pharmacology, Biochemistry and Behavior, Vol. 22, No. 5, 1985, p. 731-735.

Research output: Contribution to journalArticle

@article{321bfe5bee764a2ab9954d9abd95a057,
title = "Effects of phencyclidine (PCP)-like drugs on turning behavior, 3H-dopamine uptake, and 3H-PCP binding",
abstract = "In this study representatives from three chemical classes which are known to produce a phencyclidine (PCP)-like discriminative stimulus cue in rats were tested for their ability to inhibit synaptosomal uptake of 3H-dopamine (3H-DA) and to compete for a binding site labeled with 3H-PCP. Although there was a good correlation between these two in vitro activities within the arylcycloalkylamine class (PCP, N-ethyl-phenylcyclohexylamine (PCE), and ketamine) it did not hold when representatives from the benzomorphans, N-allylnormetazocine (NANM), cyclazocine (CYCL), and ethylketocyclazocine (EKC), or a substituted dioxolane (etoxadrol) were included. At some dose each of these drugs with the exception of EKC also produced ipsilateral turning in rats with a unilateral 6-hydroxydopamine lesion of the substantia nigra. This effect was also not well correlated with inhibition of 3H-DA uptake. However, a significant correlation was found to exist between turning behavior and affinity for the putative PCP/sigma receptor. The possibility that a non-dopaminergic mechanism involving the PCP/sigma receptor underlies the ability of these agents to induce turning behavior is discussed.",
keywords = "H-Phencyclidine binding, Cyclazocine, Dopamine uptake, Ethylketocyclazocine, Etoxadrol, Ketamine, N-Allylnormetazocine, Phencyclidine, Turning behavior",
author = "Johnson, {Kenneth M.} and Snell, {Lawrence D.}",
year = "1985",
doi = "10.1016/0091-3057(85)90521-0",
language = "English",
volume = "22",
pages = "731--735",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Effects of phencyclidine (PCP)-like drugs on turning behavior, 3H-dopamine uptake, and 3H-PCP binding

AU - Johnson, Kenneth M.

AU - Snell, Lawrence D.

PY - 1985

Y1 - 1985

N2 - In this study representatives from three chemical classes which are known to produce a phencyclidine (PCP)-like discriminative stimulus cue in rats were tested for their ability to inhibit synaptosomal uptake of 3H-dopamine (3H-DA) and to compete for a binding site labeled with 3H-PCP. Although there was a good correlation between these two in vitro activities within the arylcycloalkylamine class (PCP, N-ethyl-phenylcyclohexylamine (PCE), and ketamine) it did not hold when representatives from the benzomorphans, N-allylnormetazocine (NANM), cyclazocine (CYCL), and ethylketocyclazocine (EKC), or a substituted dioxolane (etoxadrol) were included. At some dose each of these drugs with the exception of EKC also produced ipsilateral turning in rats with a unilateral 6-hydroxydopamine lesion of the substantia nigra. This effect was also not well correlated with inhibition of 3H-DA uptake. However, a significant correlation was found to exist between turning behavior and affinity for the putative PCP/sigma receptor. The possibility that a non-dopaminergic mechanism involving the PCP/sigma receptor underlies the ability of these agents to induce turning behavior is discussed.

AB - In this study representatives from three chemical classes which are known to produce a phencyclidine (PCP)-like discriminative stimulus cue in rats were tested for their ability to inhibit synaptosomal uptake of 3H-dopamine (3H-DA) and to compete for a binding site labeled with 3H-PCP. Although there was a good correlation between these two in vitro activities within the arylcycloalkylamine class (PCP, N-ethyl-phenylcyclohexylamine (PCE), and ketamine) it did not hold when representatives from the benzomorphans, N-allylnormetazocine (NANM), cyclazocine (CYCL), and ethylketocyclazocine (EKC), or a substituted dioxolane (etoxadrol) were included. At some dose each of these drugs with the exception of EKC also produced ipsilateral turning in rats with a unilateral 6-hydroxydopamine lesion of the substantia nigra. This effect was also not well correlated with inhibition of 3H-DA uptake. However, a significant correlation was found to exist between turning behavior and affinity for the putative PCP/sigma receptor. The possibility that a non-dopaminergic mechanism involving the PCP/sigma receptor underlies the ability of these agents to induce turning behavior is discussed.

KW - H-Phencyclidine binding

KW - Cyclazocine

KW - Dopamine uptake

KW - Ethylketocyclazocine

KW - Etoxadrol

KW - Ketamine

KW - N-Allylnormetazocine

KW - Phencyclidine

KW - Turning behavior

UR - http://www.scopus.com/inward/record.url?scp=0021922042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021922042&partnerID=8YFLogxK

U2 - 10.1016/0091-3057(85)90521-0

DO - 10.1016/0091-3057(85)90521-0

M3 - Article

VL - 22

SP - 731

EP - 735

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 5

ER -